Electrospun Amorphous Solid Dispersions with Lopinavir and Ritonavir for Improved Solubility and Dissolution Rate
Nanomaterials · 28.09.2024 · 14 (19) · 1569
DOI: 10.3390/nano14191569 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nanomaterials, online erschienen am 28.09.2024. Verfasst von Ewelina Łyszczarz und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Technology and Biopharmaceutics, Faculty of Pharmacy, Jagiellonian University Medical College, Medyczna 9, 30-688 Cracow…. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science Centre, Poland, Strategic Program Excellence Initiative at Jagiellonian University, European Union in the framework of the Smart Growth Operational Programme, Measure 4.2.
Abstract (Originalsprache)
Lopinavir (LPV) and ritonavir (RTV) are two of the essential antiretroviral active pharmaceutical ingredients (APIs) characterized by poor solubility. Hence, attempts have been made to improve both their solubility and dissolution rate. One of the most effective approaches used for this purpose is to prepare amorphous solid dispersions (ASDs). To our best knowledge, this is the first attempt aimed at developing ASDs via the electrospinning technique in the form of fibers containing LPV and RTV. In particular, the impact of the various polymeric carriers, i.e., Kollidon K30 (PVP), Kollidon VA64 (KVA), and Eudragit® E100 (E100), as well as the drug content as a result of the LPV and RTV amorphization were investigated. The characterization of the electrospun fibers included microscopic, DSC, and XRD analyses, the assessment of their wettability, and equilibrium solubility and dissolution studies. The application of the electrospinning process led to the full amorphization of both the APIs, regardless of the drug content and the type of polymer matrix used. The utilization of E100 as a polymeric carrier for LPV and KVA for RTV, despite the beads-on-string morphology, had a favorable impact on the equilibrium solubility and dissolution rate. The results showed that the electrospinning method can be successfully used to manufacture ASDs with poorly soluble APIs.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmaceutical Technology and Biopharmaceutics, Faculty of Pharmacy, Jagiellonian University Medical College, Medyczna 9, 30-688 Cracow, Poland.
- Doctoral School of Medicinal and Health Sciences, Jagiellonian University Medical College, Św. Łazarza 16, 31-530 Cracow, Poland.
- Department of Chemical Technology, Faculty of Chemistry, Jagiellonian University, Gronostajowa 2, 30-387 Cracow, Poland.
ORCID-Profile: Ewelina Łyszczarz, Aleksandra Rezka, Aleksander Mendyk
Förderung
- National Science Centre, Poland
- Strategic Program Excellence Initiative at Jagiellonian University
- European Union in the framework of the Smart Growth Operational Programme, Measure 4.2
- Strategic Programme Excellence Initiative at Jagiellonian University
- European Union
Zitieren
APA
Łyszczarz, E., Sosna, O., Srebro, J., Rezka, A., Majda, D., & Mendyk, A. (2024). Electrospun Amorphous Solid Dispersions with Lopinavir and Ritonavir for Improved Solubility and Dissolution Rate. Nanomaterials, 14(19), 1569. https://doi.org/10.3390/nano14191569
Vancouver
Łyszczarz E, Sosna O, Srebro J, Rezka A, Majda D, Mendyk A. Electrospun Amorphous Solid Dispersions with Lopinavir and Ritonavir for Improved Solubility and Dissolution Rate. Nanomaterials. 2024;14(19):1569. doi:10.3390/nano14191569
BibTeX
@article{yszczarz2024,
author = {Łyszczarz, Ewelina and Sosna, Oskar and Srebro, Justyna and Rezka, Aleksandra and Majda, Dorota and Mendyk, Aleksander},
title = {Electrospun Amorphous Solid Dispersions with Lopinavir and Ritonavir for Improved Solubility and Dissolution Rate},
journal = {Nanomaterials},
year = {2024},
volume = {14},
number = {19},
pages = {1569},
doi = {10.3390/nano14191569}
}
EUVIMED